Serum Heparanase Level Is Decreased in Stable Coronary Artery Disease

OBJECTIVE: Heparanase (HPA), mammalian endo-β-D-glu­cu­ronidase, separates heparan sulfate chains of proteoglycans and changes the structure of the extracellular matrix. We investigated whether serum levels of HPA differ in patients with stable coronary artery disease (SCAD) and subjects with normal...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Med Princ Pract
Egile Nagusiak: Gurbuz, Ahmet Seyfeddin, Ozturk, Semi, Efe, Suleyman Cagan, Yilmaz, Mehmet Fatih, Yanik, Raziye Ecem, Yaman, Ali, Kirma, Cevat
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: S. Karger AG 2019
Gaiak:
Original Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6944950/
https://ncbi.nlm.nih.gov/pubmed/31480068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000503085
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak